Girisopam
From Self-sufficiency
| 180px | |
| Systematic (IUPAC) name | |
|---|---|
|
1-(3-chlorophenyl)- 7,8-dimethoxy- 4-methyl- 5H-2,3-benzodiazepine | |
| Identifiers | |
| CAS Number | 82230-53-3 |
| ATC code | none |
| PubChem | CID 71257 |
| Chemical data | |
| Formula | C18H17ClN2O2 |
| Molar mass | 328.79[[Script error: No such module "String".]] |
Girisopam (GYKI-51189) is a drug which is a 2,3-benzodiazepine derivative, related to tofisopam.[1] It has selective anxiolytic action with no sedative, anticonvulsant or muscle relaxant effects.[2][3][4]
See also
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />
| 35px | This drug article relating to the nervous system is a stub. You can help ssf by expanding it. |
- ↑ Psychotropics.dk
- ↑ Andrási F, Horváth K, Sineger E, Berzsenyi P, Borsy J, Kenessey A, Tarr M, Láng T, Kórösi J, Hámori T. Neuropharmacology of a new psychotropic 2,3-benzodiazepine. Arzneimittelforschung. 1987 Oct;37(10):1119-24.
- ↑ Horváth K, Andrási F, Botka P, Hámori T. Anxiolytic profile of girisopam and GYKI 52,322 (EGIS 6775). Comparison with chlordiazepoxide and buspirone. Acta Physiologica Hungarica. 1992;79(2):153-61.
- ↑ Horváth EJ, Salamon C, Bakonyi A, Fekete MI, Palkovits M. [(3)H]-girisopam, a novel selective benzodiazepine for the 2, 3-benzodiazepine binding site. Brain Research. Brain Research Protocols. 1999 Jul;4(2):230-5.
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Benzodiazepines
- Organochlorides
- Phenol ethers
- Nervous system drug stubs
- 2Fix
